A CRUCIAL step in the application of immunology to the management of cancer is the demonstration of tumour-associated antigens on human neoplasms. A wide variety of approaches to this problem has been made (Grimm et al., 1976; Gorsky, Vanky and Sulitzeanu, 1976; Richman, 1976; Hellstrom and Hellstrom, 1974a; Shiku et al., 1976) including the production of heteroantisera to membrane antigens of cancer cells (Mohanakumar, Metzgar and Miller, 1974) . This latter approach is of special interest, because it allows the production of large quantities of serum which can be used to analyse tumour cell surfaces. In addition, immunization of another species is likely to result in the production of free antibody which can be detected in antibodybinding techniques; whereas the demonstration of antibody to tumour antigens in sera of cancer patients may be rendered difficult because antibody may be complexed with antigen, especially in patients with large tumour masses (Hellstrom and Hellstrom, 1974b) .
Antibodies to membrane antigens unmodified by preparative procedures are more likely to be obtained by injection of whole tumour cells than of cell fractions. However, sera produced by either method are likely to contain antibodies to "normal" human antigens, and attempts have been made to improve the specificity of these sera for tumour antigens by coating the immunizing cells with antibodies raised to "normal" antigens, thereby reducing the immunogenicity of the latter . Nonetheless, a number of problems concerning the production of heteroantisera to tumour antigens remain, namely:
(i) Whilst adequate numbers of leukaemia cells can be obtained to immunize species such as the rabbit (Brown, Capellaro and Stuhlmiller and Seigler, 1975) it is more difficult to obtain adequate numbers of cells from solid tumours. Even when attempts are made to culture cells from solid tumours in order to obtain sufficient quantities for immunization, it has still proved difficult to obtain adequate numbers of cells free from contaminating "normal" cells.
(ii) Despite attempts to improve specificity of sera as outlined above, antibodies to "normal" antigens may still be present. In order to screen for such antibodies, it is necessary to have a variety of "normal" target cells. Furthermore, if antibody binding to these target cells is demonstrated, methods of absorption are required which involve the production of adequate numbers of normal cells for this purpose, and the development of techniques of absorption which avoid loss of antisera.
(iii) Methods of assay for antibodies to tumour-associated antigens should be de- 
MATERIALS AND METHODS

Cell culture
All cells were grown in glass medicine bottles (usually the 11 size) as monolayer cultures in 30 ml of tissue culture medium (RF20) which consists of 20 ml of foetal calf serum (Flow Labs) 80 ml of RPMI 1640 49 (Gibco Biocult), 1 ml of penicillin/streptomycin at 10,000 u/ml (Gibco Biocult) and 1.5 ml of 200 mm glutamine (Gibco Biocult) giving a final volume of 102-5 ml of stock solution. The flasks were gassed in 95% air-5% C02 and incubated at 370C. When cultures were reaching confluency, cells were removed from flasks in a mixture of 0 25% trypsin (Gibco Biocult) in Ca and Mg free Earle's balanced salt solution (BSS) and Versene (1/5000 strength, Gibco Biocult) in a ratio of 1: 4 to give the working solution.
(a) Malignant cells.-Malignant ascitic and pleural effusions were obtained fresh and sterile from local hospitals. The effusions were either added to 11 flasks with no further manipulation, or centrifuged at 1500 rev/min for 45 min; the supernatant was then removed, and the pellet was resuspended in tissue culture medium and pipetted into a flask (Souhami, Owen and Seeger, 1974) . Either method normally yielded a confluent monolayer in about one week, the centrifugation technique accelerated this process, so that confluence was reached 2-3 days earlier. The cells were passaged until sufficient numbers were obtained for the immunization programme and a stock of cells was cryopreserved using a controlled biological freezer (Cryosan BV4) under optimal conditions (manuscript in preparation) and stored in a liquid-N2 refrigerator.
(b) Non-malignant cells.-All normal cells, except a continuous line of Chang cells (human liver) were obtained from solid tissue which, after transportation to the laboratory, was chopped into 1 mm3 fragments or less and set up in tissue culture. They grew to form monolayers which could then be treated as above.
Production of sera (a) Anti-human-lymphocyte serum (ALS).-Tonsils, obtained from the local hospital, were washed in BSS supplemented with antibiotics to reduce the risk of inducing septicaemia in the rabbit to be immunized. Tonsils were teased in BSS and the suspension was allowed to stand for 10 min to allow large particles to settle. The supernatant was removed and centrifuged at 225 g for 10 min. Slides wNere scanned in a Leitz epi-illumination microscope (Ploenopak 2) using an oilimmersion x 60 objective.
Controls were set up in parallel, using the same procedure except that sera obtained from rabbits prior to immunization wiere added instead of immune sera. In addition, tests were performed on cells using media alone in place of serum prior to the addition of conjugate.
(b) 125I-staphylococcal protein A (1251-SpA) assay. The basic principle is the saine as that utilized in the indirect immunofluorescence assay; in this case 1251-SpA replaces the fluorescein conjugate. Ten 1u of cell suspension was added to each w%ell of a micro-wrell plate (Falcon Plastics Code No. 3034) and culture mediumNwas added to the interspaces betwreen wells to humidify the plate. The plate w%as then placed in a humidified desiccator, gassed with air/500 C02 and incubated at 37°C overnight.
The number of cells required to form a confluent monolayer varies between cell types (e.g. 15 x 103 Chang cells per well, 2 X 1(3 adult fibroblasts per well). This was determined empirically. Prior to the start of the assay, the plates were immersed in phosphate buffered saline (PBS) and gently rocked to remove any unattached cells. The wells w-ere then firmly blotted twice with filter paper to remove most of the fluid. Ten microlitres of diluted sera (immune or control) or tissue culture media was pipetted into appropriate wells. Plates were incubated for 30 min at room temperature and washed 2 x in 150 ml lots of PBS and blotted.
SpA (Pharmacia) was iodonated by the Chloramine-T method (Hunter, 1973) 150 mg of SpA was reacted with 1 mC. of Na1251I (Radiochemicals, Amersham, England) and the sp. act. wAas usually about 6 mCi/mg SpA. A 1: 250 dilution of 1251--SpA in culture mediuin (Hepes) was added to each well 732 in 10 jkl aliquots and incubated as above.
Plates were washed 4 x in PBS (300 ml in total) blotted, air dried and sprayed with Nubecutane (Astra Chemicals Ltd) to prevent cell detachment. Wells were cut out on a band saw and counted on a gamma counter. At each stage in the assay, the condition of the cells was checked using an inverted microscope.
Each set of data was obtained from wells in triplicate or quintuplicate.
Absorption of sera
Antisera were absorbed on confluent monolayers of cells grown in large glass flasks (surface area, 180 cm2). Culture medium was drained to the base of the flask by incubating the flask vertically "on end" for 20 min. This medium was removed and the flask was tightly stoppered and replaced "on end" for a further 20 min, so that any residual medium could be removed. The antiserum to be absorbed was then pipetted into the flask and allowed to cover the cell monolayer. The cells and antiserum were incubated together for 45 min at 37°C after which the flask was again placed "on end" and allowed to stand for 10 min. The antiserum was then recovered. Three batches of anti-melanoma serum all derived from the same serum pool, were absorbed separately on cell monolayers. All 3 batches were diluted 1:5 with foetal calf serum prior to absorption. Subsequently, batch 1 was absorbed X27 on Chang cells, X 7 on foetal fibroblasts, X 2 on fibroadenoma cells and finally x 3 on colon carcinoma cells. II, III and IV). Titres of antibody up to 1: 2000 were found, indicating that the sera require extensive absorption with Chang cells to remove antibodies to ''normal" human antigens.
Reactivity of Chang-cell-absorbed sera with other cells Twenty or more absorptions using confluent monolayers of Chang cells in large flasks were required to remove anti-Chang activity. However, after all activity to Chang cells had been removed, residual antibody-binding activity in antimelanoma and anti-breast-carcinoma sera to tumour cells was detected in both assays (Tables II, III, IV and Fig. 4 ). This could not be removed by further absorption with Chang cells. In the case of anti-ovarian-carcinoma serum and anticolon-carcinoma serum, very little residual activity could be demonstrated, and these two sera were not examined further.
It should be noted that the immunofluorescence pattern indicates binding of antibody to membrane antigens (Fig. 3) . This is expected, since tests were carried out on unfixed cells.
Activity of Chang-absorbed sera for human cells other than tumour cells was noted in both assays (Tables II, III and  IV) . Steps were taken to remove this activity by absorbing both anti-melanoma and anti-breast-carcinoma sera with foetal fibroblasts. One batch of anti-melanoma serum (batch 3) was absorbed, however, with pleural cells instead of foetal fibroblasts (Table III) .
Reactivity of anti-tumour sera absorbed by both Chang cells and foetal fibroblasts
Further absorption of serum with foetal fibroblasts removed activity to these cells, but left good residual activity to tumour cells in the case of anti-melanoma serum and anti-breast-carcinoma serum (Tables II and IV) . In addition to the loss of activity to foetal fibroblasts, activity to certain primary cultures of normal human cells was also removed by absorption on fibroblasts monolayers. For instance, activity to pleural cells (1) and t In the 1251-SpA assay, the titre of an antibody is defined as the lowest dilution of antisera whose arithmetic mean -s.e. gave a higher value than the arithmetic mean of the control wells +s.e. Control wells were incubated with rabbit serum drawn prior to immunization or medium alone. The latter two gave comparable results except in the case of serum drawn from the rabbit prior to immunization with melanoma cells. Here, a low titre of antibody was detected and this could be absorbed entirely with Chang cells. fibro-adenoma cells was lost in the case of anti-melanoma sera (batch 1) and anti-human breast-carcinoma serum. However, with certain other normal human cells, low levels of antibody activity were still detected, i.e. pleural cells (2) were still reactive with both antimelanoma and anti-breast-carcinoma sera (Tables II and IV) . In both cases, it should be noted that IF tests indicated that only certain cells in the total cell population were positive.
Because absorption with foetal fibroblasts may remove activity to oncofoetal antigens, Batch 3 of the anti-melanoma sera was absorbed with pleural cells after preliminary Chang absorption. However, the results (Table III (Batches 1 and 2) , anti-breastcarcinoma serum (Batch 3). Batches 1 and 2 of anti-breast-carcinoma sera were not further studied because they had low titres to the breast carcinoma (1) (Tables II, III and IV) . Although titres were low, membrane immunofluorescence was bright and the entire cell population was stained. The counts obtained in the 1251-SpA assay were quite high (see Fig. 4 ).
Absorption of residual activity for tumour cells by unrelated tumour cells
The fact that various tumour cells reacted with the same sera suggested that common antigens may be being detected, and this was confirmed by showing that absorption of anti-melanoma serum with colon carcinoma or ovarian carcinoma cells removed all activity to both tumours as well as to other tumourcell types (Tables II, III and IV) . Similarly, absorption of anti-breast-carcinoma sera with ovarian carcinoma cells gave us comparable results. In the case of anti-melanoma serum (Batch 3) where some reactivity to normal cells was still present prior to absorption with unrelated tumour cells, all reactivity to normal and tumour cells was removed.
DISCUSSION
In this study we have employed primary cell cultures so as to avoid problems that are associated with use of established cell lines, such as contamination with Hela cells (Grimwade, 1976 ) viral contamination and loss of antigenicity through prolonged culture (Levey, 1973) . Our primary cell cultures have limited proliferative potential and so, in order to allow experiments over a (Hellstrom and Hellstrom, 1975 (Cailleau et al., 1974; Whitehead and Hughes, 1975 To ensure that the absorption with foetal fibroblasts had not removed antibodies to foetal antigens which may be responsible for the histogenic pattern of human tumour antigens described by other workers, anti-melanoma serum (Batch 3) was absorbed with Chang and pleural cells (1) (see Table III ). The serum remained reactive to the tumours and some normal cells at this stage. The serum was then absorbed with colon carcinoma, and this removed all reactivity to tumour and non-tumour cells tested. The experiment indicates firstly, that absorption with foetal fibroblasts is not responsible for the failure to detect histogenically-determined antigens in the )revious experiments, and secondly, the great similarity between the set of antigens on the colon carcinoma cells and the set on the melanoma cells.
Other workers have claimed that tumour cells share common tumour antigens (Dickinson, Smith and Dyson, 1976; Seibert et al., 1977; Grimm et al., 1976) and our results are more in keeping with this interpretation rather than the histogenic model of tumour antigens. However, there is evidence, especially in the case of melanoma, that histogenically determined tumour-specific antigens are present (McCoy et al., 1975; Stuhlmiller and Seigler, 1975; Shiku et al., 1976) but differences in approach make direct comparisons difficult.
There are several possible reasons why histogenic tumour-specific antigens were not detected in the present study. Firstly Oreaves et al. (1975) were low and comparable with those found in this paper after reactivity to normal cells had been lost. However, these titres could still be used as a diagnostic or prognostic tool .
In 
